Innovation empowers physicians to treat their patients effectively
India Medtronic Private Limited, a wholly-owned subsidiary of Dublin-headquartered Medtronic plc (NYSE: MDT), has launched EEA™ Circular Stapler with Tri-Staple™ Technology – the first 3-row Circular Stapler with varied height staples for use in colorectal procedures, where safer anastomosis (surgical connection between two loops of the intestine) is required to avoid any leaks.
“Meaningful innovations are not only limited to a new product. They can also offer a novel, even disruptive, way of delivering an existing treatment to empower physicians to treat their patients effectively,” Madan Krishnan, Vice President & Managing Director, India Medtronic Pvt Ltd, said on 24 Dec 2020 in Mumbai, launching the latest technology in India.
“The Tri-Staple™ EEA™ circular stapler is the latest addition to Medtronic’s Tri-staple technology portfolio. Medtronic has been at the forefront of innovation and we have evolved our products through continuous technological innovation in all aspects of their design, materials & delivery mechanism,” he said.
The new Tri-Staple™ Technology comprises a sloped cartridge face that delivers less stress on the tissue. It also offers consistent performance over a broad range of tissue thickness and allows for greater perfusion into the staple line.
The EEA™ circular stapler with Tri-Staple™ technology is indicated for use in colorectal procedures, where safer anastomosis (the surgical connection between two loops of the intestine) is required to avoid any leaks.
The device has three rows of varied height staples to deliver 30% more security to the staple line and requires 60% lesser firing force in the operating room as compared to current devices.
Moreover, the device comes with improved audible and tactile feedback that enables clinicians with better decision-making in the operating room. Additionally, the tilt-top mechanism on the device facilitates easy removal during colorectal surgeries. The promise of higher security and greater perfusion at the staple line is expected to deliver better clinical outcomes for patients.
The EEA™ circular stapler with Tri-Staple™ technology is designed to work in harmony with the natural properties of the tissue before, during and after stapling. With its stepped cartridge face, the Tri-Staple™ technology delivers graduated compression that optimizes the interaction between the tissue and stapler.
Medtronic plc, headquartered in Dublin, is among the world’s largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world.
Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together. #health #technology #innovation #manufacturing /fiinews.com